{"nct_id":"NCT03398148","title":"A Multicenter, Randomized, Double-Blind, Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Ulcerative Colitis","status":"COMPLETED","status_verified_date":"2025-01","start_date":"2018-03-07","start_date_type":"ACTUAL","primary_completion_date":"2022-11-09","primary_completion_date_type":"ACTUAL","completion_date":"2023-05-11","completion_date_type":"ACTUAL","phases":["PHASE2","PHASE3"],"tickers":["ABBV"]}